Formulation and Evaluation of a Mucoadhesive Thermoresponsive System Containing Brazilian Green Propolis for the Treatment of Lesions Caused by Herpes Simplex Type I

• Autor(a) principal: Mazia, Renata Sespede
• Data de Publicação: 2016
• Outros Autores: Araujo Pereira, Raphaela Regina de [UNESP], Belloto de Francisco, Lizziane Maria, Marcal Natali, Maria Raquel, Dias Filho, Benedito Prado, Nakamura, Celso Vataru, Bruschi, Marcos Luciano, Ueda-Nakamura, Tania
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1016/j.xphs.2015.11.016; http://hdl.handle.net/11449/159040
• topic: herpes simplex type I; Brazilian green propolis; mucoadhesive; viscoelastic; rheology

The aim of the present work was to develop a topical delivery system that contains Brazilian green propolis extract (PE-8) to increase efficiency and convenience when applied to herpetic lesions. The cytotoxicity and antiherpetic activity was determined in vitro and in vivo. The PE-8 was added to a system that contained poloxamer 407 and carbopol 934P. The in vitro characterization of the system included rheological studies, texture profile analysis, and mucoadhesion analysis. The PE-8 inhibited the virus during the phase of viral infection, induced virion damage, and exhibited an ability to protect cells from viral infection. The system had advantageous mucoadhesive properties, including a suitable gelation temperature of approximately 25 degrees C for topical delivery, a desirable textural profile, and pseudoplastic behavior. The in vitro release study showed a rapid initial release of the PE-8 in the first 3 h, and the rate of drug release remained constant for up to 24 h. The system appeared to be macroscopically and microscopically innocuous to skin tissue. Therefore, the mucoadhesive thermoresponsive system that contained the PE-8 appears to be promising for increasing bioavailability and achieving prolonged release of the PE-8 when applied to skin lesions caused by herpes simplex virus type 1. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.